Versatile Electroanalytical Bioplatforms for Simultaneous Determination of Cancer-Related DNA 5-Methyl- and 5-Hydroxymethyl-Cytosines at Global and Gene-Specific Levels in Human Serum and Tissues.


Journal

ACS sensors
ISSN: 2379-3694
Titre abrégé: ACS Sens
Pays: United States
ID NLM: 101669031

Informations de publication

Date de publication:
25 01 2019
Historique:
pubmed: 1 12 2018
medline: 29 1 2020
entrez: 1 12 2018
Statut: ppublish

Résumé

This paper reports the preparation of versatile electrochemical biosensing platforms for the simple, rapid, and PCR-independent detection of the most frequent DNA methylation marks (5-methylcytosine, 5-mC, and/or 5-hydroxymethylcytosine, 5-hmC) both at global and gene-specific levels. The implemented strategies, relying on the smart coupling of immuno-magnetic beads (MBs), specific DNA probes and amperometric detection at screen-printed carbon electrodes (SPCEs), provided sensitive and selective determination of the target methylated DNAs in less than 90 min with a great reproducibility and demonstrated feasibility for the simultaneous detection of the same or different cytosine epimarks both at global level and in different loci of the same gene or in different genes. The bioplatforms were applied to determine global methylation events in paraffin-embedded colorectal tissues and specific methylation at promoters of tumor suppressor genes in genomic DNA extracted from cancer cells and paraffin-embedded colorectal tissues, and in serum without previous DNA extraction from cancer patients.

Identifiants

pubmed: 30499292
doi: 10.1021/acssensors.8b01339
doi:

Substances chimiques

Antibodies, Monoclonal 0
Biomarkers, Tumor 0
Fluorescent Dyes 0
RASSF1 protein, human 0
Tumor Suppressor Proteins 0
5-hydroxymethylcytosine 1123-95-1
5-Methylcytosine 6R795CQT4H
DNA 9007-49-2
Hydrogen Peroxide BBX060AN9V
Horseradish Peroxidase EC 1.11.1.-
DNA Modification Methylases EC 2.1.1.-
MGMT protein, human EC 2.1.1.63
DNA Repair Enzymes EC 6.5.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

227-234

Auteurs

Eloy Povedano (E)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid , E-28040 Madrid , Spain.

Víctor Ruiz-Valdepeñas Montiel (VR)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid , E-28040 Madrid , Spain.

Alejandro Valverde (A)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid , E-28040 Madrid , Spain.

Fernando Navarro-Villoslada (F)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid , E-28040 Madrid , Spain.

Paloma Yáñez-Sedeño (P)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid , E-28040 Madrid , Spain.

María Pedrero (M)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid , E-28040 Madrid , Spain.

Ana Montero-Calle (A)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid , E-28040 Madrid , Spain.

Rodrigo Barderas (R)

UFIEC , Instituto de Salud Carlos III , 28220 Majadahonda, Madrid , Spain.

Alberto Peláez-García (A)

Molecular Pathology and Therapeutic Targets Group Hospital Universitario La Paz IdiPAZ , 28046 Madrid , Spain.

Marta Mendiola (M)

Molecular Pathology and Therapeutic Targets Group Hospital Universitario La Paz IdiPAZ , 28046 Madrid , Spain.
Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) , Instituto de Salud Carlos III , 28029 Madrid , Spain.

David Hardisson (D)

Molecular Pathology and Therapeutic Targets Group Hospital Universitario La Paz IdiPAZ , 28046 Madrid , Spain.

Jaime Feliú (J)

Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) , Instituto de Salud Carlos III , 28029 Madrid , Spain.
Translational Oncology Group Hospital Universitario La Paz IdiPAZ , 28046 Madrid , Spain.

Jordi Camps (J)

Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d́Investigació Sanitària Pere Virgili , Universitat Rovira i Virgili , E-43204 Reus , Spain.

Elisabet Rodríguez-Tomàs (E)

Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d́Investigació Sanitària Pere Virgili , Universitat Rovira i Virgili , E-43204 Reus , Spain.
Department of Radiation Oncology, Hospital Universitari Sant Joan, Institut d́Investigació Sanitària Pere Virgili , Universitat Rovira i Virgili , E-43204 Reus , Spain.

Jorge Joven (J)

Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d́Investigació Sanitària Pere Virgili , Universitat Rovira i Virgili , E-43204 Reus , Spain.

Meritxell Arenas (M)

Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d́Investigació Sanitària Pere Virgili , Universitat Rovira i Virgili , E-43204 Reus , Spain.

Susana Campuzano (S)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid , E-28040 Madrid , Spain.

José M Pingarrón (JM)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid , E-28040 Madrid , Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH